Effect of capsae inhibition on thymic apoptosis in hemorrhagic shock

Journal of Investigative Surgery

Volumn 20, Issue 2, 2007, Pages 97-103

  Bini, Roberto ^a   Cursio, Raffaele ^b   Belhacene, Nathalie ^c   Giudicelli, Jean ^d   Ferruà, Bernard ^b   Olivero, Giorgio ^a   Auberger, Patrick ^c   Mari, Bernard ^c   Gugenheim, Jean ^b   Cotogni, Paolo ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITÉ CÔTE D'AZUR   (France)

^c INSERM   (France)

^d CENTRE DE BIOCHIMIE   (France)

Author keywords

Apoptosis; Hemorrhage; Shock; Thymus; TNF ; Z vad FMK

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE; CREATININE; TRIACYLGLYCEROL LIPASE; TUMOR NECROSIS FACTOR ALPHA; UREA; BENZYLOXYCARBONYLVALYL ALANYL ASPARTYL FLUOROMETHYL KETONE; BENZYLOXYCARBONYLVALYL-ALANYL-ASPARTYL FLUOROMETHYL KETONE; ENZYME INHIBITOR; PEPTIDE CHLOROMETHYL KETONE; UNCLASSIFIED DRUG;

AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOKINE RELEASE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMORRHAGIC SHOCK; MALE; NONHUMAN; ORGAN INJURY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; RESUSCITATION; SPRAGUE DAWLEY RAT; THYMOCYTE; TRIACYLGLYCEROL LIPASE BLOOD LEVEL; UREA BLOOD LEVEL; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; PATHOLOGY; THYMUS; TIME;

AMINO ACID CHLOROMETHYL KETONES; ANIMALS; APOPTOSIS; CASPASES; ENZYME INHIBITORS; MALE; RATS; RATS, SPRAGUE-DAWLEY; SHOCK, HEMORRHAGIC; THYMUS GLAND; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34247636636     PISSN: 08941939     EISSN: 15210553     Source Type: Journal    
DOI: 10.1080/08941930701235445     Document Type: Article

References (38)

1. Demetriades, D., Smith, J. S., Jacobson, L. E., Moncure, M., Minei, J., Nelson, B. J. and Scannon, P. J. (1999) Bactericidal/ permeability-increasing protein (rBPI21) in patients with hemorrhage due to trauma: Results of a multicenter phase II clinical trial. rBPI21 Acute Hemorrhagic Trauma Study Group. J Trauma., 46, pp. 667-676.
2. Regel, G., Grotz, M., Weltner, T., Sturm, J. A. and Tscherne, H. (1996) Pattern of organ failure following severe trauma. World J Surg., 20, pp. 422-429.
3. Wang, S. D., Huang, K. J., Lin, Y. S. and Lei, H. Y. (1994) Sepsis-induced apoptosis of the thymocytes in mice. J Immunol., 152, pp. 5014-5021.
4. Ayala, A. and Chaudry, I. H. (1995) Dietary n-3 polyunsaturated fatty acid modulation of immune cell function before or after trauma. Nutrition, 11, pp. 1-11.
5. Barke, R. A., Roy, S., Chapin, R. B. and Charboneau, R. (1994) The role of programmed cell death (apoptosis) in thymic involution following sepsis. Arch Surg, 129, pp. 1256-1261.
6. Xu, Y. X., Wichmann, M. W., Ayala, A., Cioffi, W. G. and Chaudry, I. H. (1997) Trauma-hemorrhage induces increased thymic apoptosis while decreasing IL-3 release and increasing GM-CSF. J Surg Res, 68, pp. 24-30.
7. Wyllie, A. H. (1980) Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature, 284, pp. 555-556.
8. Baseta, J. G. and Stutman, O. (2000) TNF regulates thymocyte production by apoptosis and proliferation of the triple negative (CD3-CD4-CD8-) subset. J Immunol., 165, pp. 5621-5630.
9. Toledo-Pereyra, L. H., Toledo, A. H., Walsh, J. and Lopez-Neblina, F. (2004) Molecular signaling pathways in ischemia/reperfusion. Exp Clin Transplant., 2, pp. 174-177.
10. Anaya-Prado, R., Toledo-Pereyra, L. H., Guo, R. F., Reuben, J., Ward, P. A. and Walsh, J. (2003) The attenuation of hemorrhage-induced liver injury by exogenous nitric oxide, L-arginine, and inhibition of inducible nitric oxide synthase. J Invest Surg., 16, pp. 247-261.
11. Vila, E. and Salaices, M. (2005) Cytokines and vascular reactivity in resistance arteries. Am J Physiol Heart Circ Physiol., 288, pp. H1016-H1021.
12. Virag, L., Scott, G. S., Cuzzocrea, S., Marmer, D., Salzman, A. L. and Szabo, C. (1998) Peroxynitrite-induced thymocyte apoptosis: The role of caspases and poly (ADP-ribose) synthetase (PARS) activation. Immunology., 94, pp. 345-355.
13. Zhou, X., Gordon, S. A., Kim, Y. M., Hoffman, R. A., Chen, Y., Zhang, X. R., Simmons, R. L. and Ford, H. R. (2000) Nitric oxide induces thymocytes apoptosis via a caspase-1-dependent mechanism. J Immunol., 165, pp. 1252-1258.
14. Dolle, R. E., Hoyer, D., Prasad, C. V., Schmidt, S. J., Helaszek, C. T., Miller, R. E. and Ator, M. A. (1994) P1 aspartate-based peptide alpha-((2,6-dichlorobenzoyl)oxy) methyl ketones as potent time-dependent inhibitors of interleukin-1 beta-converting enzyme. J Med Chem, 37, pp. 563-564.
15. Slee, E. A., Zhu, H., Chow, S. C., MacFarlane, M., Nicholson, D. W. and Cohen, G. M. (1996) Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD.FMK) inhibits apoptosis by blocking the processing of CPP32. Biochem J., 315, pp. 21-24.
16. Daemen, M., Veer, C Van't, Deneker, G., Heemskerk, V. H., Wolfs, T., Clauss, M., Vandenabeele, P. and Buurman, W. A. (1999) Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation. J Clin Invest, 104, pp. 541-549.
17. Yaoita, C. J., Ogawa, K., Maehara, K. and Maruyama, Y. (1998) Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor. Circulation, 97, pp. 276-281.
18. Soeda, J., Miyagawa, S., Sano, K., Masumoto, J., Taniguchi, S. and Kawasaki, S. (2001) Cytochrome c release into cytosol with subsequent caspase activation during warm ischemia in rat liver. Am J Gastrointest Liver Physiol, 281, p. G1115.
19. Mauriz, J. L., Gonzalez, P., Jorquera, F., Olcoz, J. L. and Gonzalez-Gallego, J. (2003) Caspase inhibition does not protect against liver damage in hemorrhagic shock. Shock, 19, pp. 33-37.
20. Guerin, S., Mari, B., Belhacene, N., Rossi, B., Peyron, J. F. and Auberger, P. (1997) CD10 (endopeptidase 24.11) is a thymic peptide-degrading enzyme possibly involved in the regulation of thymocyte functions. Cell Immunol, 175, pp. 85-91.
21. Cursio, R., Gugenheim, J., Ricci, J. E., Crenesse, D., Rostagno, P., Maulon, L., Saint-Paul, M. C., Ferrua, B. and Auberger, A. P. (1999) A caspase inhibitor fully protects rats against lethal normothermic liver ischemia by inhibition of liver apoptosis. FASEB J, 13, pp. 253-261.
22. Herrant, M., Luciano, F., Loubat, A. and Auberger, P. (2002) The protective effect of phorbol esters on Fas-mediated apoptosis in T cells. Transcriptional and postranscriptional regulation. Oncogene, 21, pp. 4957-4568.
23. Mapstone, J., Ian, R. and Evans, P. (2003) Fluid resuscitation strategies: A systemic review of animal trials. J Trauma, 55, pp. 571-589.
24. Totapally, B. R., Fakioglu, H., Torbati, D. and Wolfsdorf, J. (2003) Esophageal capnometry during hemorrhagic shock and after resuscitation in rats. Crit Care, 7, pp. 79-84.
25. Argent, N. B., Liles, J., Rodham, D., Clayton, C. B., Wilkinson, R. and Baylis, P. H. (1994) A new method for measuring the blood volume of the rat using 113 m indium as a tracer. Lab Anim, 28, pp. 172-175.
26. Schumacher, J., Binkowski, K., Dendorfer, A. and Klotz, K. (2003) Organ-specific extravasation of albumin-bound Evans blue during nonresuscitated hemorrhagic shock in rats. Shock, 20, pp. 565-568.
27. Rivera-Chavez, F. A., Toledo-Pereyra, L. H., Martinez-Mier, G., Nora, D. T., Harkema, J., Bachulis, B. L. and Dean, R. E. (2001) L-selectin blockade and liver function in rats after uncontrolled hemorrhagic shock. J Invest Surg, 14, pp. 7-12.
28. Tsukada, K., Hasegawa, T., Tsutsumi, S. and Kuwano, H. (2000) Roles of cyclooxygenase-2 in tissue injury during hemorrhagic shock. Shock, 13, pp. 392-396.
29. Sakorafas, G. H., Tsiotos, G. G. and Sarr, M. G. (2000) Ischemia/ reperfusion-induced pancreatitis. Dig Surg, 17, pp. 3-14.
30. Natori, S., Higuchi, H., Contreras, P. and Gores, G. J. (2003) The caspase inhibitor IDN-6556 prevents caspase activation and apoptosis in sinusoidal endothelial cells during liver preservation injury. Liver Transpl, 9, pp. 278-284.
31. Jiang, J., Bahrami, S., Leichtfried, G., Redl, H., Ohlinger, W. and Schlag, G. (1995) Kinetics of endotoxin and tumor necrosis factor appearance in portal and systemic circulation after hemorrhagic shock in rats. Ann Surg, 221, pp. 100-106.
32. Santibanez-Gallerani, A. S., Barber, A. E., Williams, S. J., Davis, S., Zhao, Y. and Shires, G. T. (2000) Matrix metalloproteinase inhibition protects hepatic integrity in hemorrhagic shock. J Gastrointest Surg, 4, pp. 536-541.
33. Altavilla, D., Cainazzo, M. M., Squadrito, F., Guarini, S., Bertolini, A. and Bazzani, C. (1998) Tumor necrosis factor-alpha as a target of melanocortins in hemorrhagic shock in the anaesthetized rat. Br J Pharmacol, 124, pp. 1587-1590.
34. Abraham, E., Bursten, S., Shenkar, R., Allbee, J., Tuder, R. and Weedson, P. (1995) Phosphatidic acid signaling mediates lung cytokine expression and lung inflammatory injury after hemorrhage in mice. J Exp Med, 181, pp. 569-575.
35. Cauwels, A., Janssen, B., Waeytens, A., Cuvelier, C. and Brouckaert, P. (2003) Caspase inhibition causes hyperacute tumor necrosis factor-induced shock via oxidative stress and phospholipase A2. Nat Immunol, 4, pp. 387-393.
36. Lopez-Neblina, F., Toledo, A. H. and Toledo-Pereyra, L. H. (2005) Molecular biology of apoptosis in ischemia and reperfusion. J Invest Surg., 18, pp. 335-350.
37. Waxman, K. (1996) Shock: Ischemia, reperfusion, and inflammation. New Horizons, 4, pp. 153-160.
38. Perfettini, J. L. and Kramer, G. (2003) Caspase activation is not death. Nat Immunol, 4, pp. 308-310.